WASHINGTON (Reuters) – U.S. President Biden will meet with the chief executives of Johnson & Johnson (NYSE:) and Merck & Co Inc at the White House on Wednesday after the companies recently announced a COVID-19 vaccine manufacturing deal, a White House official said on Monday.
The president had been expected to attend an event with the CEOs during a visit on Wednesday to vaccine manufacturer Emergent Biosolutions (NYSE:), but the trip to the company’s Baltimore facility was canceled, the official said.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Be the first to comment